India's Morepen secures approval of anti-allergy API Loratadine for export to China

India-based Morepen Laboratories, a global leader in Active Pharmaceutical Ingredient (API) manufacturing, has received ...

April 1, 2025 | Tuesday | News
Apollomics and LaunXP ink $50 M deal for NSCLC treatment in Asia

US-based Apollomics Inc., a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates t...

April 2, 2025 | Wednesday | News
Taiwan explores biotech and pharma collaborations with India

In a strategic move to strengthen its position in the global life sciences sector, Taiwan is actively seeking partnershi...

March 28, 2025 | Friday | News
Advancing Green Pharmaceuticals: Sustainable Biomanufacturing Practices Across Asia Pacific

According to WHO, modern health systems contribute around 5% of global carbon emissions. Around half of these emissions ...

March 31, 2025 | Monday | Opinion
“ADCs have already become a mainstay treatment option across a variety of both hematologic and solid cancers”

Can you provide an overview of the primary components of ADCs and how they work in general?  Antibody-drug conjuga...

March 31, 2025 | Monday | Opinion
There are over 650 cell and gene therapy clinical trials underway in APAC region

What are the company’s major plans in store for 2025, particularly for the APAC region?  The pharmaceutical ...

March 31, 2025 | Monday | Opinion
Trump's tariff war threatens to disrupt pharma supply chain

Import tariffs have emerged as a key trade issue since President Donald Trump took office on January 20, 2025. Among the...

March 31, 2025 | Monday | Analysis
Alumis and Kaken Pharma announce collaboration worth $140 M for dermatology treatment in Japan

Alumis Inc., a US-based clinical-stage biopharmaceutical company and Japan's Kaken Pharmaceutical Co. have entered into ...

March 27, 2025 | Thursday | News
Merck inks $2 B agreement with Hengrui Pharma for cardiovascular drug

Merck, known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., a global pharmaceu...

March 27, 2025 | Thursday | News
Esyms and DHL eCommerce partner to change medicine distribution in Malaysia

Esyms, a leading online pharmacy and health solutions provider, is collaborating with DHL eCommerce, a domestic parcel d...

March 27, 2025 | Thursday | News
China's Bio-Thera inks biosimilar deal with India-based Dr. Reddy's for Southeast Asia region

Bio-Thera Solutions, a China-based biopharmaceutical company developing a pipeline of innovative therapies and biosimila...

March 26, 2025 | Wednesday | News
United Laboratories and Novo Nordisk ink $2 B deal for treatment of obesity, diabetes and others

China based The United Laboratories International Holdings Limited (TUL) and Danish pharmaceutical company Novo Nordisk ...

March 25, 2025 | Tuesday | News
Lindström starts operations in Vietnam to introduce pharma workwear

Lindström has opened a new service centre in Southern Vietnam, marking the beginning of its operations in the count...

March 24, 2025 | Monday | News
Singapore gives nod to GSK's Omjjara (momelotinib) as first treatment indicated for myelofibrosis patients with anaemia

GSK Singapore has announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related spleno...

March 24, 2025 | Monday | News
AstraZeneca announces investment of $2.5 B to establish sixth global strategic R&D centre in China

British pharmaceutical company AstraZeneca has announced an investment of $2.5 billion in Beijing to establish its sixth...

March 24, 2025 | Monday | News
Primo partners with ABX to bring PB01 closer to Taiwan's prostate cancer market

In response to the growing burden of prostate cancer in Taiwan, Primo Biotechnology has formed a strategic partnership w...

March 21, 2025 | Friday | News
Japan's Taiho Pharma buys ADC firm Araris Biotech for $740 M

Japan-based Taiho Pharmaceutical and Araris Biotech AG, a Swiss biotechnology company developing next-generation antibod...

March 20, 2025 | Thursday | News
Indian pharma firm Cipla signs multi-regional licensing deal for ophthalmic care with Taiwan's Formosa

India-based Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals for the comme...

March 18, 2025 | Tuesday | News
BIOPLUS-INTERPHEX KOREA 2025: Pioneering the Future of Biopharma with Specialized Pavilions

Showcasing Innovation Through Specialized Pavilions BIX 2025 will spotlight four specialized pavilions, each dedicated ...

March 17, 2025 | Monday | News
Teva enhances pharma distribution system in China

Teva Hong Kong has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network (KLN)....

March 14, 2025 | Friday | News
Trends shaping the Healthcare and Bioscience industries in 2025

The year 2025 is set to be a pivotal year for the health, bioscience, and biopharma sectors, as emerging trends shape he...

March 11, 2025 | Tuesday | Opinion
Taiwan's Mycenax and Sartorius join forces to strengthen global biopharma manufacturing potentials

Taiwan's Mycenax and Sartorius have entered into a strategic partnership to create comprehensive biopharmaceutical manuf...

March 6, 2025 | Thursday | News
WuXi XDC and AbTis announce strategic partnership to advance next-generation ADCs

WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...

March 11, 2025 | Tuesday | News
Vetter boosts pharmaceutical storage capacity with major warehouse expansion

Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced a significant exp...

March 11, 2025 | Tuesday | News
Japan grants Orphan Drug Designation to Lundbeck's potential treatment for Multiple System Atrophy

The Ministry of Health, Labour, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundb...

March 11, 2025 | Tuesday | News